Elena Hitraya
Overview
Explore the profile of Elena Hitraya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
62
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sasso E, Mabey B, Flake 2nd D, Hitraya E, Chin C, Ben-Shachar R, et al.
PLoS One
. 2024 May;
19(5):e0296459.
PMID: 38709770
Background: A multi-biomarker disease activity (MBDA)-based cardiovascular disease (CVD) risk score was developed and internally validated in a Medicare cohort to predict 3-year risk for myocardial infarction (MI), stroke or...
2.
Hitraya E, Gaidarova S, Piera-Velazquez S, Jimenez S
Connect Tissue Res
. 2024 Mar;
65(2):161-169.
PMID: 38436275
Objective: The COL1A1 proximal promoter contains two GC-rich regions and two inverted CCAAT boxes. The transcription factors Sp1 and CBF bind to the GC sequence at -122 to -115 bp...
3.
Curtis J, Xie F, Crowson C, Sasso E, Hitraya E, Chin C, et al.
Arthritis Res Ther
. 2020 Dec;
22(1):282.
PMID: 33276814
Background: Rheumatoid arthritis (RA) patients have increased risk for cardiovascular disease (CVD). Accurate CVD risk prediction could improve care for RA patients. Our goal is to develop and validate a...
4.
Curtis J, Flake D, Weinblatt M, Shadick N, Ostergaard M, Hetland M, et al.
Rheumatology (Oxford)
. 2018 Dec;
58(5):874-883.
PMID: 30590790
Objective: To develop and evaluate an adjusted score for the multi-biomarker disease activity (MBDA) test to account for the effects of age, sex and adiposity in patients with RA. Methods:...
5.
Curtis J, Wright G, Strand V, Davis C, Hitraya E, Sasso E
Arthritis Rheumatol
. 2016 Nov;
69(4):863-865.
PMID: 27813312
No abstract available.
6.
Wang J, Devenport J, Low J, Yu D, Hitraya E
Arthritis Care Res (Hoboken)
. 2015 Oct;
68(6):882-5.
PMID: 26473986
Objective: To clarify the relevance of measuring interleukin-6 (IL-6) and C-reactive protein (CRP) levels in order to predict clinical response to tocilizumab (TCZ) in rheumatoid arthritis patients. Methods: In a...
7.
Ogale S, Hitraya E, Henk H
BMC Musculoskelet Disord
. 2011 Sep;
12:204.
PMID: 21929807
Background: The role of biologic therapies in the treatment of rheumatoid arthritis has expanded, but dosing patterns in the first versus subsequent lines of therapy have not been thoroughly explored....